Latest news with #Strategy27
RTÉ News
23-05-2025
- Business
- RTÉ News
Pamela McCreedy elected President of CAI
Pamela McCreedy has been elected President of Chartered Accountants Ireland, making her the first public sector professional in 17 years to take on the role. Ms McCreedy is also the first president to be elected since the Institute's historic amalgamation with CPA Ireland. Her appointment was confirmed at the 137th Annual General Meeting in Belfast, the first AGM the amalgamation took effect on 1 September 2024. With almost 40,000 members and 6,600 students across Ireland and internationally, Chartered Accountants Ireland is now the largest professional body on the island. Ms McCreedy is currently serving as Chief Operating Officer of the Police Service of Northern Ireland (PSNI) and previously held senior roles in the Northern Ireland Audit Office, the Northern Health and Social Care Trust and KPMG. Commenting on her appointment, Ms McCreedy said: "I am immensely proud that the Chain of Office is being handed over in Belfast. It's a privilege to lead the Institute at such a transformative time when the pace of change in our profession is matched only by the scale of opportunity ahead. "We must meet that change with integrity, insight, and purpose. I look forward to working with members across the island and abroad to strengthen our impact and build on our proud legacy." She also paid tribute to outgoing President Barry Doyle, commending his tireless efforts in leading the Institute through amalgamation, engaging with members, and abroad, and championing SMEs, emerging talent, and responsible innovation, including AI. Looking to the year ahead Ms Creedy said the implementation of Strategy 27 is a central priority. The Institute's three-year strategic framework aims to strengthen the profession's resilience, relevance, and influence. "Strategy27 is a bold and timely blueprint," Ms McCreedy said. "In a complex world of rising costs, geopolitical pressures, and technological acceleration, the trusted role of the Chartered Accountant is more important than ever. Our members are not just finance professionals they are ethical leaders, critical thinkers, and stewards of long-term value."
Yahoo
20-05-2025
- Business
- Yahoo
SGS Announces ISO 17025 Accreditation of Canadian Pharmaceutical Lab Now Offering Extractables and Leachables Testing
MISSISSAUGA, ON, May 20, 2025 /PRNewswire/ - SGS, the world's leading testing, inspection, and certification company, has gained ISO 17025 accreditation to now offer extractables and leachables (E&L) testing through its Mississauga laboratory. This facility specializes in delivering biologics, chemistry and microbiological testing to pharmaceutical, biopharmaceutical, and medical device manufacturers across North America, while also being in close proximity to Toronto, Ontario, where just over half of Canada's pharmaceutical companies are located. The availability of this service in Canada will increase SGS's E&L testing capacity for North American clients. In addition to the Mississauga Center of Excellence, SGS's U.S.-based laboratory in Fairfield New Jersey offers E&L testing services. "The demand for extractables and leachables testing is on the rise to validate drug safety in both new drug discovery and novel drug development processes," said Joseph Bower, Head of Health Science for SGS in North America. "We are pleased to achieve ISO 17025 accreditation of our Mississauga Center of Excellence since it reflects the high standards we uphold in our laboratory operations and reinforces our position as a trusted service provider to the pharma industry." ISO 17025 is an internationally recognized benchmark that demonstrates lab competence when it comes to quality management, documentation, and equipment management. The accreditation also aligns with SGS's Strategy 27, which sets ambitious growth targets to respond to megatrends impacting the testing, inspection and certification sector, particularly market demands for greater quality assurance. SGS's Mississauga-based laboratory provides contract testing services for the pharmaceutical, biopharmaceutical, and medical device segments. Although many SGS labs in North America and worldwide are ISO 17025 accredited, together with E&L testing services, this accreditation strengthens the quality-control at every level. The facility is Health Canada and FDA registered, as well as GMP certified. It also carries the ISO 9001:2015 and ISO 13485:2016 (design and manufacture of medical devices) accreditations. With 20 laboratories across 11 countries in North America, Europe, and Asia, SGS represents the broadest, wholly owned, global network of contract analytical laboratories. As such, it is well positioned to deliver harmonized solutions to large pharmaceutical and biotechnology firms, while also being able to service smaller manufacturers with bundled or stand-alone testing services. The company also provides Phase I-IV clinical trial management, and services encompassing data management and statistics such as PK/PD modeling and simulation, pharmacovigilance, and regulatory consultancy services. ABOUT SGS SGS is the world's leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability. Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource. SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW). View original content: SOURCE SGS Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
20-05-2025
- Business
- Cision Canada
SGS Announces ISO 17025 Accreditation of Canadian Pharmaceutical Lab Now Offering Extractables and Leachables Testing
MISSISSAUGA, ON, May 20, 2025 /CNW/ - SGS, the world's leading testing, inspection, and certification company, has gained ISO 17025 accreditation to now offer extractables and leachables (E&L) testing through its Mississauga laboratory. This facility specializes in delivering biologics, chemistry and microbiological testing to pharmaceutical, biopharmaceutical, and medical device manufacturers across North America, while also being in close proximity to Toronto, Ontario, where just over half of Canada's pharmaceutical companies are located. The availability of this service in Canada will increase SGS's E&L testing capacity for North American clients. In addition to the Mississauga Center of Excellence, SGS's U.S.-based laboratory in Fairfield New Jersey offers E&L testing services. "The demand for extractables and leachables testing is on the rise to validate drug safety in both new drug discovery and novel drug development processes," said Joseph Bower, Head of Health Science for SGS in North America. "We are pleased to achieve ISO 17025 accreditation of our Mississauga Center of Excellence since it reflects the high standards we uphold in our laboratory operations and reinforces our position as a trusted service provider to the pharma industry." ISO 17025 is an internationally recognized benchmark that demonstrates lab competence when it comes to quality management, documentation, and equipment management. The accreditation also aligns with SGS's Strategy 27, which sets ambitious growth targets to respond to megatrends impacting the testing, inspection and certification sector, particularly market demands for greater quality assurance. SGS's Mississauga-based laboratory provides contract testing services for the pharmaceutical, biopharmaceutical, and medical device segments. Although many SGS labs in North America and worldwide are ISO 17025 accredited, together with E&L testing services, this accreditation strengthens the quality-control at every level. The facility is Health Canada and FDA registered, as well as GMP certified. It also carries the ISO 9001:2015 and ISO 13485:2016 (design and manufacture of medical devices) accreditations. With 20 laboratories across 11 countries in North America, Europe, and Asia, SGS represents the broadest, wholly owned, global network of contract analytical laboratories. As such, it is well positioned to deliver harmonized solutions to large pharmaceutical and biotechnology firms, while also being able to service smaller manufacturers with bundled or stand-alone testing services. The company also provides Phase I-IV clinical trial management, and services encompassing data management and statistics such as PK/PD modeling and simulation, pharmacovigilance, and regulatory consultancy services. ABOUT SGS SGS is the world's leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability. Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource. SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).
Cision Canada
02-05-2025
- Business
- Cision Canada
SGS Strengthens Industrial Operational Technology Services with the Acquisition of Streamline Control
BLOOMFIELD, N.J., May 2, 2025 /CNW/ -SGS, the world's leading testing, inspection and certification company, is pleased to announce the acquisition of Streamline Control, a prominent North American provider of industrial control systems and operational technology services. Streamline Control supports organizations across the renewable energy, utilities, oil and gas, and manufacturing sectors. Founded in 2011, Streamline Control brings to SGS a proven track record of successfully delivering modern control systems that drive digital transformation, leveraging the Industrial Internet of Things (IIoT) and other best-in-class technologies. This acquisition strengthens SGS's capabilities across North America and expands its offering to both existing clients and new prospects in industrial markets. "Many of our North American clients depend on industrial control systems for the continuity of their operations. These systems are essential to ensuring the availability and performance of their products and services," said Patrick Beck, Head of Industrial Services at SGS North America. "From IIoT-enabled sensors that monitor pipeline integrity in real time, to systems that track and optimize energy use across distributed utility networks, organizations are increasingly relying on accurate, real-time data. With the acquisition of Streamline Control, we're excited to offer fully integrated digital solutions—whether building from the ground up or enhancing existing systems—to improve efficiency, reduce costs, and deliver clearer data for better decision-making." This acquisition supports SGS's Strategy 27 by reinforcing its position as a leader in digital capabilities and next-generation technologies. Industrial organizations are accelerating investments in digital transformation to maintain competitiveness and grow market share. Streamline Control's services include SCADA (Supervisory Control and Data Acquisition) system integration and modernization. When paired with IIoT, SCADA becomes a powerful platform for advanced data management, industrial analytics, and cybersecurity—enabling industrial operations to connect, optimize, and protect their environments. As part of the acquisition, 45 skilled professionals from Streamline Control will join SGS's regional team in North America. "This is an exciting new chapter for us," said Jeremiah Hannley, CEO of Streamline Control. "Becoming part of SGS provides access to greater resources, global reach, and the opportunity to scale our impact. Most importantly, the core of who we are remains unchanged—our exceptional team, our dedication to our clients, and our passion for delivering excellence." ABOUT SGS SGS is the world's leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability. Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource. SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).
